Valuation: IRADIMED CORPORATION

Market Cap 1.24B 1.08B 1B 922M 1.74B 119B 1.78B 11.96B 4.7B 58.5B 4.66B 4.56B 201B P/E 2026 *
50.8x
P/E 2027 * 44.8x
Enterprise Value 1.24B 1.08B 1B 922M 1.74B 119B 1.78B 11.96B 4.7B 58.5B 4.66B 4.56B 201B EV / Sales 2026 *
13.6x
EV / Sales 2027 * 12.3x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.76%
1 week-0.17%
Current month+1.54%
1 month+5.24%
3 months+3.54%
6 months-4.87%
Current year-0.26%
1 week 90.83
Extreme 90.83
98.61
1 month 90.18
Extreme 90.18
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
20/06/26 Fiscal year

Chief Financial Officer

13,911 0.1088%
04/06/26 Sell

Director

-3,000 0.0235%
01/06/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-0.17%+71.16%+109.12% 1.24B
-1.21%+1.26%-13.71%-19.02% 13.35B
-6.37%-15.89%+41.04%-11.18% 3.86B
-4.45%-0.26%-35.24%-60.78% 1.18B
-4.35%-2.94%-40.50%-47.30% 1.09B
-3.75%+6.82%-42.81% - 940M
-8.55%-20.41%+61.00%+89.90% 490M
+5.01%+12.02%+47.47% - 335M
+1.55%+1.73%-56.66%+239.01% 265M
+0.98%+4.18%+31.48%+58.86% 151M
Average -2.19%+0.31%+6.32%+44.83% 2.29B
Weighted average by Cap. -2.50%-0.26%-1.18%-7.82%

Financials

2026 *2027 *
Net sales 91.2M 79.7M 73.54M 67.79M 128M 8.78B 131M 879M 346M 4.3B 343M 335M 14.81B 101M 88.18M 81.37M 75M 141M 9.72B 144M 973M 383M 4.76B 379M 371M 16.38B
Net income 24.55M 21.45M 19.8M 18.25M 34.39M 2.36B 35.16M 237M 93.07M 1.16B 92.2M 90.17M 3.99B 27.8M 24.29M 22.42M 20.66M 38.95M 2.68B 39.81M 268M 105M 1.31B 104M 102M 4.51B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
17/07/26 US$97.03 -0.76% 129,671
16/07/26 US$97.77 +4.43% 97,387
15/07/26 US$93.62 +2.13% 125,542
14/07/26 US$91.67 -6.16% 176,010
13/07/26 US$97.69 +0.50% 136,395
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
97.03USD
Average target price
118.00USD
Spread / Average Target
+21.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock